An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use
Open Access
- 9 August 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (6) , 357-365
- https://doi.org/10.1056/nejm199008093230601
Abstract
The eosinophilia—myalgia syndrome is a newly recognized illness that has been associated with the consumption of tryptophan products. It is not known whether the cause is related to the tryptophan itself or to chemical constituents introduced by the manufacturing process.This publication has 16 references indexed in Scilit:
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity?Published by American Medical Association (AMA) ,1990
- Eosinophilia-myalgia linked with L-tryptophanThe Lancet, 1990
- Hypersensitivity Pneumonitis and Pulmonary Vasculitis with Eosinophilia in a Patient Taking an L-Tryptophan PreparationAnnals of Internal Medicine, 1990
- Tryptophan metabolism in women with breast cancerInternational Journal of Cancer, 1988
- Induction of Tryptophan DegradationIn VitroandIn Vivo: A γ-Interferon-Stimulated ActivityJournal of Interferon Research, 1986
- Clinical Epidemiology of Toxic-Oil SyndromeNew England Journal of Medicine, 1983
- Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.The Journal of Experimental Medicine, 1983
- TOXIC EPIDEMIC SYNDROME, SPAIN, 1981The Lancet, 1982